A phase I-II study of the combination of bendamustine and pomalidomide with dexamethasone in patients with relapsed or refractory multiple myeloma

Category Primary study
JournalBlood
Year 2015
This article has no abstract
Epistemonikos ID: 8eb7af2b51b9cd8f499431080fb12c53ea66c5a6
First added on: Feb 07, 2025